LITTLE KNOWN FACTS ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS?.

Dependant on the subgroup analysis, we identified that there was sizeable heterogeneity with regard to mortality, favorable results, and the entire therapy powerful fee. Regarding mortality, The rationale for heterogeneity within the subgroup of edaravone dexborneol and EDV was mostly attributed to dissimilarities in drug dosage. Relating to favora